Bruno Ramalho

We’re thrilled to share groundbreaking news: the Slovenian government has awarded €1 million in public funding to the CTNNB1 Foundation to support the development of URBAGEN — the world’s first gene therapy for CTNNB1 Syndrome. This is the first time a government has publicly backed a nonprofit-led gene therapy at such an early stage. The …

Slovenia Awards €1M to CTNNB1 Foundation – A Breakthrough for Rare Disease Treatment Read More »